11/13
08:05 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
Low
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
10/18
11:01 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock.
Medium
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $10.00 price target on the stock.
10/18
10:51 am
huma
Rating for HUMA
Medium
Report
Rating for HUMA
10/10
09:36 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Medium
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
10/10
09:36 am
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Medium
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
10/10
09:32 am
huma
Rating for HUMA
Medium
Report
Rating for HUMA
10/10
09:32 am
huma
Rating for HUMA
Medium
Report
Rating for HUMA
9/20
12:19 pm
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
Low
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $13.00 price target on the stock.
9/20
12:17 pm
huma
Rating for HUMA
Low
Report
Rating for HUMA
9/5
01:16 pm
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Low
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
9/5
01:16 pm
huma
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
Low
Report
Humacyte, Inc. (NASDAQ: HUMA) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $15.00 price target on the stock.
9/5
12:40 pm
huma
Rating for HUMA
Low
Report
Rating for HUMA
9/5
12:40 pm
huma
Rating for HUMA
Low
Report
Rating for HUMA